RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 137 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $113,472 | +7.9% | 105,067 | +28.9% | 0.00% | – |
Q2 2023 | $105,187 | -9.8% | 81,541 | -7.7% | 0.00% | – |
Q1 2023 | $116,668 | +11.2% | 88,385 | +26.4% | 0.00% | – |
Q4 2022 | $104,887 | +155.8% | 69,925 | +100.2% | 0.00% | – |
Q3 2022 | $41,000 | +127.8% | 34,936 | +111.5% | 0.00% | – |
Q2 2022 | $18,000 | -97.6% | 16,515 | -93.3% | 0.00% | -100.0% |
Q1 2022 | $738,000 | -5.3% | 247,124 | -16.0% | 0.00% | 0.0% |
Q4 2021 | $779,000 | – | 294,332 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |